ProPublica

Journalism in the Public Interest

Cancel
Dollars for Docs logo

Dollars for Docs

IN COOPERATION WITH

In recent years, drug companies have started releasing details of the payments they make to doctors and other health professionals for promotional talks, research and consulting. As of 2013, 17 companies published the information, most because of legal settlements. Use this tool to search for payments. Read more about the data »

Interested in downloading the data? Go to the ProPublica Data Store.

Has Your Health Professional Received Drug Company Money?

Example searches: Klein, Duke University, Miami

With 3.5 Million records, this database represents:

Cash $4 billion

in disclosed payments

Pharma 17

companies

Pie-2 ~ 50%

of total market share

Payments in Your State

Click on a state to see payments made to practitioners and institutions there. See notes below.

State Total
Alabama $52,323,542
Alaska $1,060,349
Arizona $65,450,100
Arkansas $22,442,598
California $491,340,883
Colorado $61,945,908
Connecticut $54,628,879
Delaware $6,524,265
District of Columbia $15,741,004
Florida $358,882,128
Georgia $117,922,876
Hawaii $5,881,572
Idaho $16,222,755
Illinois $135,157,148
Indiana $76,430,761
Iowa $18,327,523
Kansas $50,427,854
Kentucky $48,103,545
Louisiana $42,349,143
Maine $6,939,383
Maryland $104,351,359
Massachusetts $200,503,955
Michigan $90,463,442
Minnesota $55,495,188
Mississippi $15,723,773
Missouri $92,939,918
Montana $5,915,431
Nebraska $61,649,329
Nevada $24,873,091
New Hampshire $9,705,358
New Jersey $103,296,994
New Mexico $12,906,740
New York $265,600,600
North Carolina $158,418,293
North Dakota $8,035,907
Ohio $158,927,259
Oklahoma $37,606,710
Oregon $40,014,961
Pennsylvania $178,719,651
Rhode Island $21,896,004
South Carolina $78,304,823
South Dakota $5,805,158
Tennessee $84,700,799
Texas $331,785,758
Utah $51,588,688
Vermont $4,264,877
Virginia $66,111,694
Washington $66,450,518
West Virginia $10,829,384
Wisconsin $44,310,420
Wyoming $599,722
Puerto Rico $21,927,260
[Unknown State] $1,240,470

Company Disclosures

The totals listed here cover different time periods and spending categories, and aren't directly comparable. See notes below. See what each company discloses »

Company Total Disclosed
AbbVie
Disclosed: July 2012 to Dec. 2013
$62.6M
Allergan
Disclosed: July 2011 to Dec. 2013
Ranges*
Amgen
Disclosed: Jan. to Dec. 2013
$42M
AstraZeneca
Disclosed: Jan. 2010 to Dec. 2013
$428.2M
Boehringer Ingelheim
Disclosed: Jan. to Dec. 2013
$99.2M
Cephalon
Disclosed: Jan. 2009 to June 2013
$99.6M
Eli Lilly
Disclosed: Jan. 2009 to Dec. 2013
$811.7M
EMD Serono
Disclosed: Jan. 2011 to Dec. 2013
$8.1M
Forest
Disclosed: Jan. 2012 to Dec. 2013
$208.8M
GlaxoSmithKline
Disclosed: April 2009 to Dec. 2013
$437.9M
Johnson & Johnson
Disclosed: Jan. 2010 to Dec. 2013
$100.5M
Merck
Disclosed: July 2009 to Dec. 2013
$724.3M
Novartis
Disclosed: Oct. 2010 to Dec. 2013
$198.6M
Pfizer
Disclosed: July 2009 to Dec. 2013
$745.2M
UCB
Disclosed: Jan. 2012 to Dec. 2013
$56.5M
Valeant
Disclosed: Jan. 10, 2010 to Dec. 2013
Ranges*
ViiV
Disclosed: Jan. 2010 to Dec. 2013
$38.6M

Notes: Companies report different types of payments for different time periods. Payments made after December 2013 are not reflected on this website. Because they are reported in ranges, some of Valeant's payments and all of Allergan's payments are excluded from state and national totals. No payments are listed for Novartis from Oct. 1, 2011 to Dec. 31, 2011 or for Valeant between Sept. 27, 2010 and Jan. 1, 2011.

Local Stories Based on This Data

See recent stories that use our data below. Interested in being notified when we update our app? Find out how.

Our Stories

20140929-dollars-for-docs-300x200_1

What We’ve Learned from Four Years of Diving into Dollars for Docs

Payments from pharmaceutical companies touch hundreds of thousands of doctors. The 17 companies we’ve tracked spent $1.4 billion in 2013 alone. Here are our top five takeaways from following all that money.

As Full Disclosure Nears, Doctors’ Pay for Drug Talks Plummets

As transparency increases and blockbuster drugs lose patent protection, drug companies have dramatically scaled back payments to doctors for promotional talks.

Dollars for Docs Mints a Millionaire

New data show drugmakers' payments to hundreds of thousands of doctors, and some have made well over $500,000.

Background Stories


Reporters, Use Our Data

Have questions about how you can best use Dollars for Docs for your own localized reporting? Contact Nicole Collins Bronzan at communications@propublica.org.

Additional reporting and development by Jason Das, Liz Day, David Frackman, Jennifer LaFleur, Jeff Larson, Dan Nguyen, Mike Tigas and Sisi Wei. Pharmacy icon from The Noun Project. The 2012 market share for the companies included in this tool was calculated using data from IMS Health, a health care information company.

Add Dollars for Docs to Your Site

We've created a Dollars for Docs widget that you can embed on any site. See it in action below, and click the "embed button" to get the code.